Back

EVS-EN 302 536 V2.1.1:2018

Short Range Devices (SRD);Radio equipment operating in the frequency range 315 kHz to 600 kHz for Ultra Low Power Animal Implantable Devices (ULP-AID) and associated peripherals;Harmonised Standard covering the essential requirements of article 3.2 of Directive 2014/53/EU

General information
Valid from 03.10.2018
Base Documents
EN 302 536 V2.1.1
Directives or regulations
None
We do not sell ETSI standards on our website. You can download them for no extra charge from here.

Standard history

Status
Date
Type
Name
03.10.2018
Main
The present document specifies technical characteristics and methods of measurements for Ultra Low Power-Animal Implant Devices (ULP-AIDs) and Peripherals as used by industry to develop new drugs and surgical techniques that provide improved health care for the benefit of human patients. ULP-AIDs operate in a Communications System using inductive technology in the frequency band 315 kHz to 600 kHz.
Table 1: Ultra Low Power Animal Implants and Peripherals
Operating in the frequency band 315 kHz to 600 kHz
Ultra Low Power Animal Implants and Peripherals service frequency bands
Transmitters - Ultra Low Power Animal Implants and Peripherals 315 kHz to 600 kHz
Receivers - Ultra Low Power Animal Implants and Peripherals 315 kHz to 600 kHz

The present document contains the technical requirements for characteristics of ULP-AID and ULP-AID-P radio equipment which are aligned with annex 12 sub-band (c) of CEPT/ERC Recommendation 70-03.
The frequency usage conditions for the bands 315 kHz to 600 kHz are EU wide harmonised for the SRD category "active medical implant devices" according to 2013/752/EU [i.6] with the following usage restrictions:
• "This set of usage conditions is only available to animal implantable devices".
The present document covers the essential requirements of article 3.2 of Directive 2014/53/EU under the conditions identified in annex A for Ultra Low Power Animal Implants and peripherals used in an implant communications system that supports development of medically related treatments that provide improved health care for patients. It does not necessarily include all the characteristics, which may be required by a user, nor does it necessarily represent the optimum performance achievable.
*
*
*
Standard monitoring